The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing MiceEmma J. Haagensen, David R. Newell|PLoS ONE|2013Cited by 13